Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/111786
Título: | Fully Automated Production of [68Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets | Autor: | Fonseca, Alexandra I. Alves, Vítor H. Hrynchak, Ivanna Alves, Francisco |
Palavras-chave: | radiopharmaceuticals; cyclotron; liquid targets; GaFAPI-46 | Data: | 12-Out-2023 | Editora: | MDPI | Projeto: | PD/BDE/150681/2020 PD/BDE/150331/2019 ICNAS-P. |
Título da revista, periódico, livro ou evento: | International Journal of Molecular Sciences | Volume: | 24 | Número: | 20 | Resumo: | 68Ga-based radiopharmaceuticals are routinely used for PET imaging of multiple types of tumors. Gallium-68 is commonly obtained from 68Ge/68Ga generators, which are limited in the quantity of activity produced. Alternatively, gallium-68 can easily be produced on a cyclotron using liquid targets. In this study, we optimized the GMP production of [68Ga]GaFAPI-46 using gallium-68 produced via a standard medical cyclotron using liquid targets. Starting from the published synthesis and quality control procedures described for other 68Ga-based radiopharmaceuticals, we have validated the synthesis process and the analytical methods to test the quality parameters of the final product to be used for routine clinical studies. [68Ga]GaFAPI-46 was successfully produced with high radiochemical purity and yield using an IBA Synthera® Extension module. Gallium chloride was produced on a medical cyclotron using a liquid target with activity of 4.31 ± 0.36 GBq at the end of purification (EOP). Analytical methods were established and validated, meeting Ph. Eur. standards. Full GMP production was also validated in three consecutive batches, producing 2.50 ± 0.46 GBq of [68Ga]GaFAPI-46 at the end of synthesis (EOS), with 98.94 ± 0.72% radiochemical purity measured via radio-HPLC. Quality was maintained for up to 3 h after the EOS. Production of [68Ga]GaFAPI-46 was performed and validated using a standard medical cyclotron with liquid targets. The quality control parameters (e.g., sterility, purity, and residual solvents) conformed to Ph. Eur. and a shelf life of 3 h was established. The activity of [68Ga]GaFAPI-46 produced was substantially higher than the one obtained with generators, enabling a better response to the clinical need for this radiopharmaceutical. | URI: | https://hdl.handle.net/10316/111786 | ISSN: | 1422-0067 | DOI: | 10.3390/ijms242015101 | Direitos: | openAccess |
Aparece nas coleções: | I&D CIBIT - Artigos em Revistas Internacionais I&D ICNAS - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Fully-Automated-Production-of-sup68supGaGaFAPI46-with-Gallium68-from-Cyclotron-Using-Liquid-TargetsInternational-Journal-of-Molecular-Sciences.pdf | 1.38 MB | Adobe PDF | Ver/Abrir |
Visualizações de página
67
Visto em 28/ago/2024
Downloads
44
Visto em 28/ago/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons